The divestiture will include V. Mueller-, Snowden-Pencer- and Genesis-branded products in addition to three manufacturing facilities in St. Louis, Cleveland and Tuttlingen, Germany. The assets included in the transaction account for annualized revenue of about $170 million, according to a June 20 news release from BD.
The deal is expected to close within BD’s fiscal year 2023, which ends Sept. 30.
About 360 BD employees will transfer to Steris after the transaction, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
